Evidence map›Paper›PMID 34360580›Full record

ArticleInternational journal of molecular sciences2021

Inhibitory Effect of Avenanthramides (Avn) on Tyrosinase Activity and Melanogenesis in α-MSH-Activated SK-MEL-2 Cells: In Vitro and In Silico Analysis.

Jun-Young Park, Hyun-Ju Choi, Tamina Park, Moon-Jo Lee, Hak-Seong Lim, Woong-Suk Yang, Cher-Won Hwang, Daeui Park, Cheorl-Ho Kim

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Multiple Antioxidative and Bioactive Molecules of Oats (Antioxidants (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Jun-Young ParkMolecular and Cellular Glycobiology Unit, Department of Biological Sciences, SungKyunKwan University, 300 Chunchun-Dong, Jangan-Gu, Suwon City 440-746, Korea.
Hyun-Ju ChoiMolecular and Cellular Glycobiology Unit, Department of Biological Sciences, SungKyunKwan University, 300 Chunchun-Dong, Jangan-Gu, Suwon City 440-746, Korea.
Tamina ParkDepartment of Predictive Toxicology, Korea Institute of Toxicology, Daejeon 34114, Korea.
Moon-Jo LeeDepartment of Herb Science, Dong-Eui Institute of Technology, Busan 47230, Korea.
Hak-Seong LimMolecular and Cellular Glycobiology Unit, Department of Biological Sciences, SungKyunKwan University, 300 Chunchun-Dong, Jangan-Gu, Suwon City 440-746, Korea.
Woong-Suk YangNodaji Co., Ltd., Pohang 37927, Korea.
Cher-Won HwangDepartment of AGEE, Handong University, Pohang 37554, Korea.
Daeui ParkDepartment of Predictive Toxicology, Korea Institute of Toxicology, Daejeon 34114, Korea.ORCID 0000-0002-9452-5849
Cheorl-Ho KimMolecular and Cellular Glycobiology Unit, Department of Biological Sciences, SungKyunKwan University, 300 Chunchun-Dong, Jangan-Gu, Suwon City 440-746, Korea.ORCID 0000-0002-6323-0714
Sungkyunkwan University · KRKorea Institute of Toxicology · KRDong-Eui University · KRHandong Global University · KR

Funding

the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry IPET 119010032HD050 derived from the IPET No.119010032CG000the Korea Institute of Toxicology 1711121217
6 · The paper itself

Abstract

Melanin causes melasma, freckles, age spots, and chloasma. Anti-melanogenic agents can prevent disease-related hyperpigmentation. In the present study, the dose-dependent tyrosinase inhibitory activity of Avenanthramide (Avn)-A-B-C was demonstrated, and 100 µM Avn-A-B-C produced the strongest competitive inhibition against inter-cellular tyrosinase and melanin synthesis. Avn-A-B-C inhibits the expression of melanogenesis-related proteins, such as TRP1 and 2. Molecular docking simulation revealed that AvnC (-7.6 kcal/mol) had a higher binding affinity for tyrosinase than AvnA (-7.3 kcal/mol) and AvnB (-6.8 kcal/mol). AvnC was predicted to interact with tyrosinase through two hydrogen bonds at Ser360 (distance: 2.7 Å) and Asn364 (distance: 2.6 Å). In addition, AvnB and AvnC were predicted to be skin non-sensitizers in mammals by the Derek Nexus Quantitative Structure-Activity Relationship system.

Indexed as

Computer Simulationalpha-MSHHormonesHumansIn Vitro TechniquesMelaninsMelanomaMolecular Docking SimulationMonophenol Monooxygenaseortho-AminobenzoatesSkinTumor Cells, Culturedalpha-MSHavenanthramide-2CHormonesMelaninsMonophenol Monooxygenaseortho-Aminobenzoatesanti-melanogenesisAvn-A-B-Cdocking simulation

Identifiers

PMID34360580
PMCPMC8345984
OpenAlexW3184548250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.